Use of a phosphorus-enriched dialysate in a hypercatabolic renal failure patient receiving intensive hemodialysis therapy.
An elderly man with end-stage renal disease required intensive hemodialysis therapy because of sepsis-induced hypercatabolism. We were able to prevent the occurrence of hypophosphatemia by using a phosphorus-enriched dialysate during hemodialysis treatments.
Zabaneh
R I
RI
Department of Medicine, Veterans Affairs Hospital, Hines, Ill. 60141, USA.
Bhatt
D M
DM
Yu
A W
AW
Tiwari
P
P
Lai
C I
CI
Leehey
D J
DJ
Ing
T S
TS
D000368:Aged; D001806:Blood Urea Nitrogen; D017809:Fatal Outcome; D015312:Hemodialysis Solutions / Q000737:chemistry*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000378:metabolism / Q000628:therapy*; D008297:Male; D010758:Phosphorus / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D006435:Renal Dialysis; D018805:Sepsis / Q000150:complications / Q000628:therapy
D015312:Hemodialysis Solutions; D010758:Phosphorus